CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR.

T André; C Louvet; F Maindrault-Goebel; C Couteau; M Mabro; J P Lotz; V Gilles-Amar; M Krulik; E Carola; V Izrael

doi:10.1016/s0959-8049(99)00150-1

CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR.

Identifier:nobleid.org/w1/20260515/48353EF1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/48353EF1.svg?ark=w1%2F20260515%2F48353EF1)](https://nobleid.org/work/w1/20260515/48353EF1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR.

Identifier:nobleid.org/w1/20260515/48353EF1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/48353EF1.svg?ark=w1%2F20260515%2F48353EF1)](https://nobleid.org/work/w1/20260515/48353EF1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work